8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-22-211873
Material agreement · Results of operations
- Item 1.01 Entry into a material definitive agreement
- Item 2.02 Results of operations and financial condition
From the SEC's structured data for this filing
Loading d390658d8k.htm…